nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—Crystalluria—Fludarabine—lymphatic system cancer	0.0705	0.0705	CcSEcCtD
Aminosalicylic Acid—Malabsorption—Methotrexate—lymphatic system cancer	0.0376	0.0376	CcSEcCtD
Aminosalicylic Acid—Non-Hodgkin's lymphoma—Mitoxantrone—lymphatic system cancer	0.0313	0.0313	CcSEcCtD
Aminosalicylic Acid—Optic neuritis—Fludarabine—lymphatic system cancer	0.0299	0.0299	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Mechlorethamine—lymphatic system cancer	0.0228	0.0228	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Carmustine—lymphatic system cancer	0.0183	0.0183	CcSEcCtD
Aminosalicylic Acid—Taste metallic—Methotrexate—lymphatic system cancer	0.0171	0.0171	CcSEcCtD
Aminosalicylic Acid—Haemolytic anaemia—Teniposide—lymphatic system cancer	0.0168	0.0168	CcSEcCtD
Aminosalicylic Acid—Lymphoma—Methotrexate—lymphatic system cancer	0.0156	0.0156	CcSEcCtD
Aminosalicylic Acid—Jaundice—Mechlorethamine—lymphatic system cancer	0.0155	0.0155	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.0148	0.0148	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Fludarabine—lymphatic system cancer	0.0133	0.0133	CcSEcCtD
Aminosalicylic Acid—Pericarditis—Methotrexate—lymphatic system cancer	0.0126	0.0126	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Teniposide—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mechlorethamine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00991	0.00991	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00984	0.00984	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mechlorethamine—lymphatic system cancer	0.00965	0.00965	CcSEcCtD
Aminosalicylic Acid—Eruption—Methotrexate—lymphatic system cancer	0.00886	0.00886	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0088	0.0088	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Carmustine—lymphatic system cancer	0.00854	0.00854	CcSEcCtD
Aminosalicylic Acid—Encephalopathy—Methotrexate—lymphatic system cancer	0.00849	0.00849	CcSEcCtD
Aminosalicylic Acid—Anaemia—Teniposide—lymphatic system cancer	0.00845	0.00845	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Teniposide—lymphatic system cancer	0.00819	0.00819	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Fludarabine—lymphatic system cancer	0.00804	0.00804	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Mitoxantrone—lymphatic system cancer	0.00794	0.00794	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Bleomycin—lymphatic system cancer	0.00765	0.00765	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00746	0.00746	CcSEcCtD
Aminosalicylic Acid—Anaemia—Fludarabine—lymphatic system cancer	0.00743	0.00743	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Fludarabine—lymphatic system cancer	0.0072	0.0072	CcSEcCtD
Aminosalicylic Acid—Anorexia—Teniposide—lymphatic system cancer	0.00712	0.00712	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00693	0.00693	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Teniposide—lymphatic system cancer	0.00649	0.00649	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.00645	0.00645	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mechlorethamine—lymphatic system cancer	0.00644	0.00644	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00643	0.00643	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00642	0.00642	CcSEcCtD
Aminosalicylic Acid—Rash—Mechlorethamine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Vincristine—lymphatic system cancer	0.00638	0.00638	CcSEcCtD
Aminosalicylic Acid—Anorexia—Fludarabine—lymphatic system cancer	0.00625	0.00625	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00621	0.00621	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Aminosalicylic Acid—Nausea—Mechlorethamine—lymphatic system cancer	0.00601	0.00601	CcSEcCtD
Aminosalicylic Acid—Jaundice—Mitoxantrone—lymphatic system cancer	0.00597	0.00597	CcSEcCtD
Aminosalicylic Acid—Urticaria—Teniposide—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Teniposide—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Teniposide—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00571	0.00571	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Fludarabine—lymphatic system cancer	0.0057	0.0057	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00566	0.00566	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Methotrexate—lymphatic system cancer	0.00559	0.00559	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00557	0.00557	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Vincristine—lymphatic system cancer	0.00553	0.00553	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Teniposide—lymphatic system cancer	0.0055	0.0055	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Aminosalicylic Acid—Anaemia—Bleomycin—lymphatic system cancer	0.00545	0.00545	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Bleomycin—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Fludarabine—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Carmustine—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Teniposide—lymphatic system cancer	0.00511	0.00511	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00483	0.00483	CcSEcCtD
Aminosalicylic Acid—Anaemia—Carmustine—lymphatic system cancer	0.00476	0.00476	CcSEcCtD
Aminosalicylic Acid—Vomiting—Teniposide—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Aminosalicylic Acid—Rash—Teniposide—lymphatic system cancer	0.00471	0.00471	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Teniposide—lymphatic system cancer	0.0047	0.0047	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Aminosalicylic Acid—Headache—Teniposide—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Carmustine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Aminosalicylic Acid—Anorexia—Bleomycin—lymphatic system cancer	0.00459	0.00459	CcSEcCtD
Aminosalicylic Acid—Anaemia—Vincristine—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fludarabine—lymphatic system cancer	0.00449	0.00449	CcSEcCtD
Aminosalicylic Acid—Nausea—Teniposide—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Aminosalicylic Acid—Anaemia—Mitoxantrone—lymphatic system cancer	0.00442	0.00442	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Vincristine—lymphatic system cancer	0.0044	0.0044	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Bleomycin—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Aminosalicylic Acid—Vomiting—Fludarabine—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Aminosalicylic Acid—Rash—Fludarabine—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fludarabine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Aminosalicylic Acid—Headache—Fludarabine—lymphatic system cancer	0.00411	0.00411	CcSEcCtD
Aminosalicylic Acid—Anorexia—Carmustine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Vincristine—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Aminosalicylic Acid—Nausea—Fludarabine—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Aminosalicylic Acid—Urticaria—Bleomycin—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Aminosalicylic Acid—Anorexia—Vincristine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Bleomycin—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mitoxantrone—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Carmustine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00363	0.00363	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Vincristine—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Carmustine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Carmustine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Vincristine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Vincristine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Aminosalicylic Acid—Urticaria—Mitoxantrone—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Carmustine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Aminosalicylic Acid—Vomiting—Bleomycin—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Aminosalicylic Acid—Rash—Bleomycin—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Bleomycin—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Vincristine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Carmustine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Aminosalicylic Acid—Nausea—Bleomycin—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Aminosalicylic Acid—Dizziness—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Aminosalicylic Acid—Vomiting—Carmustine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Aminosalicylic Acid—Dizziness—Vincristine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Aminosalicylic Acid—Rash—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Carmustine—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Aminosalicylic Acid—Headache—Carmustine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Aminosalicylic Acid—Vomiting—Vincristine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Aminosalicylic Acid—Rash—Vincristine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Aminosalicylic Acid—Headache—Vincristine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Aminosalicylic Acid—Nausea—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Aminosalicylic Acid—Rash—Mitoxantrone—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Aminosalicylic Acid—Headache—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Aminosalicylic Acid—Nausea—Vincristine—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Aminosalicylic Acid—Nausea—Mitoxantrone—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Aminosalicylic Acid—Urticaria—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Aminosalicylic Acid—Dizziness—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Aminosalicylic Acid—Vomiting—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methotrexate—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Aminosalicylic Acid—Headache—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Aminosalicylic Acid—Nausea—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
